1Ve' ronique L. Roger, Alan S. Go, et al. Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Associa- tion[ J]. Circulation ,2011, ( 1 ) : 123.
4Vera Regitz-Zagrosek and Ute Seeland. Sex and gender differences in myocardial hypertrophy and heart failure [ J]. Wien Med Wochen- schr,2011,161 (5) : 109 - 116.
5Ho KK,Pinsky JL,Kannel WB,et al. The epidemiology of heart fail- ure : the Framingham Study [ J ]. J Am Coll Cardiol, 1993,22 : 6A - 13A.
6He J,Ogden LG,Bazzano LA,et al. Risk factors for congestive heart failure in US men and women. NHANES I Epidemiology Follow-up Study [ J ]. Arch Intern Med,2001,161 : 996 - 1002.
7Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and ra- cial differences in peripartum cardiomyopathy [ J ]. Am J Cardiol, 2007, 100: 302.
8Brueks S, Little WC, Chao T, et al. Relation of anemia to diastolic heart failure and the effect on outcome [ J ]. Am J Cardiol, 2004, 93:1055 - 1057.
9Regitz-Zagrosek V, Brokat S, Tschope C. Role of Gender in HF with normal left ventricular ejection fraction [ J ]. Prog Cardiovasc Dis, 2007,49: 241 -251.
10Ghali JK, Pina IL, Gottlieb SS, et al. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) [ J]. Circulation,2002,105: 1585.
1Yoshimura K,Kadoyama K,Sakaeda T,et al.A survey of the FAERS database concerning the adverse event profiles of alpha1-adrenoreceptor blockers for lower urinary tract symptoms.Int J Med Sci,2013,10:864-869.
2Roger VL,Go AS,Lloyd-Jones DM,et al.Heart disease and stroke statistics-2011 update:a report from the American Heart Association.Circulation,2011,123:e18-e209.
3Minushkina LO.Features of urapidil in treatment of resistant hypertension.Kardiologiia,2012,52:77-82.
5Stewart S,MacIntyre K,Hole DJ,et al. More malignant than cancer.Five-year survival following a first admission for heart failure [ J ]. EurJ Heart Fail,2001,3(3) :315-322.
6Adams KF. New epidemiology perspectives concerning mild-to-mod-erate heart failure[ J]. Am J Med,2001 (110) :6-13.
7Massie BM,Shah NB. Evolving trends in the epidemidogic factor ofheart failure : rational for preventive and comprehensive disease man-agement [J]. Am Heart J,1997(133) :703-712.
